Format
Items per page
Sort by

Send to:

Choose Destination

Results: 6

Cited In for PubMed (Select 19638960)

1.

Antibacterial activity of the human host defence peptide LL-37 and selected synthetic cationic lipids against bacteria associated with oral and upper respiratory tract infections.

Leszczynska K, Namiot D, Byfield FJ, Cruz K, Zendzian-Piotrowska M, Fein DE, Savage PB, Diamond S, McCulloch CA, Janmey PA, Bucki R.

J Antimicrob Chemother. 2013 Mar;68(3):610-8. doi: 10.1093/jac/dks434. Epub 2012 Nov 7.

2.

A novel polyethyleneimine-coated adeno-associated virus-like particle formulation for efficient siRNA delivery in breast cancer therapy: preparation and in vitro analysis.

Shao W, Paul A, Abbasi S, Chahal PS, Mena JA, Montes J, Kamen A, Prakash S.

Int J Nanomedicine. 2012;7:1575-86. doi: 10.2147/IJN.S26891. Epub 2012 Mar 23.

3.

Interaction of 3β-amino-5-cholestene with phospholipids in binary and ternary bilayer membranes.

Lönnfors M, Engberg O, Peterson BR, Slotte JP.

Langmuir. 2012 Jan 10;28(1):648-55. doi: 10.1021/la203589u. Epub 2011 Dec 14.

4.

Polymers for improving the in vivo transduction efficiency of AAV2 vectors.

Moulay G, Boutin S, Masurier C, Scherman D, Kichler A.

PLoS One. 2010 Dec 28;5(12):e15576. doi: 10.1371/journal.pone.0015576.

5.

AAV's anatomy: roadmap for optimizing vectors for translational success.

Mitchell AM, Nicolson SC, Warischalk JK, Samulski RJ.

Curr Gene Ther. 2010 Oct;10(5):319-40.

6.

Combined antibacterial and anti-inflammatory activity of a cationic disubstituted dexamethasone-spermine conjugate.

Bucki R, Leszczynska K, Byfield FJ, Fein DE, Won E, Cruz K, Namiot A, Kulakowska A, Namiot Z, Savage PB, Diamond SL, Janmey PA.

Antimicrob Agents Chemother. 2010 Jun;54(6):2525-33. doi: 10.1128/AAC.01682-09. Epub 2010 Mar 22.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk